Show source-provided references
5. Incorporation of Robust NIR‐II Fluorescence Brightness and Photothermal Performance in a Single Large π‐Conjugated Molecule for Phototheranostics
7. Molecular Programming of NIR‐IIb‐Emissive Semiconducting Small Molecules for In Vivo High‐Contrast Bioimaging beyond 1500 nm
10.1002/adma.202201263 ↗9. Finely Tunable NIR‐II Organic Scaffolds for Fluorescence/Photoacoustic Duplex Imaging–guided Noninvasive Photothermal Therapy of Glioblastoma
10.1002/agt2.680 ↗10. An Extended NIR‐II Superior Imaging Window from 1500 to 1900 nm for High‐Resolution In Vivo Multiplexed Imaging Based on Lanthanide Nanocrystals
10.1002/anie.202311883 ↗11. Side‐Chain‐Tuned Molecular Packing Allows Concurrently Boosted Photoacoustic Imaging and NIR‐II Fluorescence
10.1002/anie.202117433 ↗12. Acceptor Engineering Produces Ultrafast Nonradiative Decay in NIR‐II Aza‐BODIPY Nanoparticles for Efficient Osteosarcoma Photothermal Therapy via Concurrent Apoptosis and Pyroptosis
10.34133/research.0169 ↗13. Simultaneously Enhancing NIR‐II Emission, Type‐I, and Type‐II Photosensitization through Acceleration of Charge‐Separated‐State Formation for Tumor Phototheranostics
10.1002/anie.202521182 ↗14. Synthesis on NIR‐II Multifunctional Imaging and Photothermal Therapy of a Novel Water‐Soluble Molecule
10.1002/adhm.202304564 ↗15. Rationally Manipulating Molecular Planarity to Improve Molar Absorptivity, NIR‐II Brightness, and Photothermal Effect for Tumor Phototheranostics
10.1016/j.biomaterials.2025.123113 ↗16. Increasing Molecular Planarity through Donor/Side‐Chain Engineering for Improved NIR‐IIa Fluorescence Imaging and NIR‐II Photothermal Therapy under 1064 nm
10.1002/anie.202215372 ↗17. Dimerization Extends π‐Conjugation of Electron Donor‐Acceptor Structures Leading to Phototheranostic Properties beyond the Sum of Two Monomers
10.1002/agt2.528 ↗19. Hierarchical Acceptor Engineering of NIR‐II Butterfly Aggregation‐Induced Emission Luminogens for Enhanced Theranostic Efficiency
10.1016/j.cej.2025.171969 ↗21. S···O Conformation Locks Synergistic Alkoxy Chain Engineering of NIR‐II Phototheranostic Molecules for Precision Hepatocellular Carcinoma Theranostics
23. Noncovalent Conformational Lock‐Based Molecular Engineering Improves NIR‐II Photoacoustic/Photothermal Performance of Semiconducting Polymer Nanoparticles for Efficient Phototheranostics
10.1007/s40843-023-2603-6 ↗24. As Aggregation‐Induced Emission Meets with Noncovalent Conformational Locks: Subtly Regulating NIR‐II Molecules for Multimodal Imaging‐Navigated Synergistic Therapies
10.1002/anie.202413219 ↗26. Less Is More: Asymmetric D–A Type Agent to Achieve Dynamic Self‐Assembled Nanoaggregates for Long‐Acting Photodynamic Therapy
10.1002/adma.202402434 ↗27. The Key Role of Molecular Packing in Luminescence Property: From Adjacent Molecules to Molecular Aggregates
10.1002/adma.202306617 ↗28. Construction of through‐Space Charge‐Transfer Nanoparticles for Facilely Realizing High‐Performance NIR‐II Cancer Phototheranostics
10.1002/adfm.202407317 ↗29. Charge Transfer‐Mediated J‐Aggregates of Azaindole Cyanine with 160 nm Absorption Redshift for Efficient NIR‐II Photothermal Tumor Therapy
10.1021/acsnano.5c09082 ↗30. A Combination of Covalent and Noncovalent Restricted‐Intramolecular‐Rotation Strategies to Develop Supramolecular Photosensitizers with Aggregation‐Induced Emission Characteristics
10.1002/agt2.676 ↗31. Revisiting Carbazole‐Based Polymer Donors for Efficient and Thermally Stable Polymer Solar Cells: Structural Utility of Coplanar π‐Bridged Spacers
10.1039/D2TA00145D ↗32. A Facile Structural Isomerization‐Induced 3D Spatial D‐A Interlocked Network for Achieving NIR‐II Phototheranostic Agents
10.1002/anie.202212673 ↗33. Flexible Regulation of Optical Properties Based on Structure Size‐Driven Intermolecular Interactions for Phototherapy
10.1002/advs.202501468 ↗34. Controlling Aggregation‐Induced Two‐Photon Absorption Enhancement via Intermolecular Interactions
10.1021/acsami.2c12436 ↗36. The Role of Intra and Intermolecular Interactions on the Conformational Dynamics of 2‐Halo‐1‐Phenylpropanols: Structure and Solvent Effects
10.1016/j.molstruc.2024.140493 ↗37. Optimizing Comprehensive Performance of Aggregation‐Induced Emission Nanoparticles via Balancing Molecular Structure Twistedness and Conjugation
10.1002/adhm.202100360 ↗39. Two‐Dimensional Infrared Spectroscopy of Antiparallel β‐Sheet Secondary Structure
10.1021/ja049811j ↗40. Cooperative Interaction between the Three Strands of a Designed Antiparallel β‐Sheet
10.1021/ja9705405 ↗41. Engineering β‐Sheet Morphologies via Metal Cross‐Linking and Side Chain Modifications
10.1039/D5SC05237H ↗42. The Rippled β‐Sheet Layer Configuration—A Novel Supramolecular Architecture Based on Predictions by Pauling and Corey
10.1039/D2SC02531K ↗44. Side‐Chain Engineering of Organic Photothermal Agents for Boosting Further Red‐Shifted Absorption and Higher Photothermal Therapeutic Effect
10.1016/j.colsurfb.2023.113611 ↗45. Deposition numbers CCDC: 2404891 (forl‐2CPFIC) and CCDC: 2404889 (forb‐2CPFIC) contain the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre Access Structures service.
47. Accurately Extracting the Signature of Intermolecular Interactions Present in the NCI Plot of the Reduced Density Gradient versus Electron Density
10.1039/C7CP02110K ↗48. The EPR Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect
10.1016/j.addr.2010.04.009 ↗49. Nano Effects′: A Review on Nanoparticle‐Induced Multifarious Systemic Effects on Cancer Theranostic Applications
10.1039/D2MA00784C ↗51. Localization of Cancer Cells for Subsequent Robust Photodynamic Therapy by ROS Responsive Polymeric Nanoparticles with Anti‐Metastasis Complexes NAMI‐A
10.1002/adma.202310298 ↗52. Reversing the Epithelial–Mesenchymal Transition in Metastatic Cancer Cells Using CD146‐Targeted Black Phosphorus Nanosheets and a Mild Photothermal Treatment
10.1021/acsnano.1c11070 ↗53. Emerging Nanomedicine Approaches Fighting Tumor Metastasis: Animal Models, Metastasis‐Targeted Drug Delivery, Phototherapy, and Immunotherapy
10.1039/C6CS00458J ↗